Cargando…
Molecular Pathophysiological Mechanisms in Huntington’s Disease
Huntington’s disease is an inherited neurodegenerative disease described 150 years ago by George Huntington. The genetic defect was identified in 1993 to be an expanded CAG repeat on exon 1 of the huntingtin gene located on chromosome 4. In the following almost 30 years, a considerable amount of res...
Autor principal: | Jurcau, Anamaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219859/ https://www.ncbi.nlm.nih.gov/pubmed/35740453 http://dx.doi.org/10.3390/biomedicines10061432 |
Ejemplares similares
-
Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy
por: Jurcau, Anamaria, et al.
Publicado: (2022) -
Mitochondria in Huntington’s disease: implications in pathogenesis and mitochondrial-targeted therapeutic strategies
por: Jurcau, Anamaria, et al.
Publicado: (2022) -
Neuroinflammation in Cerebral Ischemia and Ischemia/Reperfusion Injuries: From Pathophysiology to Therapeutic Strategies
por: Jurcau, Anamaria, et al.
Publicado: (2021) -
Molecular Mechanisms of Neuroinflammation in Aging and Alzheimer’s Disease Progression
por: Andronie-Cioara, Felicia Liana, et al.
Publicado: (2023) -
The Link between Oxidative Stress, Mitochondrial Dysfunction and Neuroinflammation in the Pathophysiology of Alzheimer’s Disease: Therapeutic Implications and Future Perspectives
por: Jurcău, Maria Carolina, et al.
Publicado: (2022)